Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Leo Skywalker's going to be flying in on the Menonillennial Falcon on Monday to take us all to the NASDAQ system...
I think with the recent sell off of the Bio's its a blessing in disguise that CTIX has had a delay in up listing. So forget about the December to remember. We are just One day away from Momentous May!
May the 4th be with us...
The rumor I heard (just started by me) was Leo is a huge Star Wars fan and was waiting for May 4th to up list!
Two days away from Momentous May! Heard Leo say he was sorry for the delay but everything's going to be okay...
Thank you for that. That's how I've felt all day. Market reaction is mind boggling. People can't read between the lines. We are on the verge of achieving something long sought after by CTIX and we are below 3 bucks! In theory CTIX could be trading on the NASDAQ as early as tomorrow!
Here they come to save the day!
Shortages of antibiotics, including those used to treat drug-resistant infections, may be putting patients at risk for sickness and death, according to a new report.
Between 2001 and 2013, there were shortages of 148 antibiotics. And the shortages started getting worse in 2007, researchers found.
"Many of the drug shortages were among the only drugs to treat a particular condition, drugs to treat antibiotic-resistant bacteria and drugs used to treat children," said lead researcher Dr. Larissa May, an associate professor of emergency medicine at George Washington University in Washington, D.C.
"When these drugs are not available, patients may not get the best care, or even die," she said. "If something isn't done, there may be big impacts on health care."
In the study, nearly half the shortages were for antibiotics needed to treat severe infections, including Clostridium difficile, carbapenem-resistant Enterobacteriaceae (CRE), methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa, among others.
C. difficile can be picked up in hospitals and doctors' offices, and in 2011 the bacteria was to blame for 500,000 infections and 29,000 deaths. MRSA is an antibiotic-resistant bacteria that infects some 78,000 people a year and can also be deadly, according to the U.S. Centers for Disease Control and Prevention.
Many of the shortages were of broad-spectrum antibiotics -- injectable drugs for which there were no alternative manufacturers. Moreover, shortages were common among antibiotics used to treat children. Among these drugs, there were few alternatives doctors could turn to, the researchers found.
"Gold-standard" therapies, such as aztreonam, which is used to treat serious infections in patients allergic to penicillin, and trimethoprim/sulfamethoxazole, used to treat pneumocystis pneumonia, were also in short supply during the study period, the findings showed.
May said a variety of factors account for these shortages. Among these are delays or problems with making a drug, including a shortage of raw materials. In addition, when a drug isn't used often, though it is essential for some patients, manufacturers may delay or stop making it, she explained.
In all, there were multiple shortages of 32 antibiotics, which lasted an average of six months. At the end of the study, 26 antibiotics remained in short supply or were not available, the researchers found.
According to May, drug companies are not required to report shortages, so hospitals and doctors are often caught off guard. Ideally, reporting shortages should be mandatory so doctors and hospitals can plan for them, she suggested.
May expects shortages to continue to increase in the coming years. "If we don't have a policy for action, we may start seeing patient deaths and other complications related to these shortages," she said.
The report was published online April 23 in the journal Clinical Infectious Diseases.
Michael Kinch, director of the Center for Research Innovation in Business at Washington University in St. Louis, said, "Antibiotics are being removed from the market six times faster than new ones are being produced."
Kinch noted there are few incentives for drug companies to develop new antibiotics. "From a commercial standpoint, you are talking about a low-margin, low-priced product. If a company has to decide to develop an antibiotic versus a new cancer drug, the obvious choice is to go with the new, more expensive drug," he said.
"The rising cost of new drug development -- about $2.6 billion per drug -- is making drug companies make a rational decision to emphasize products where they are likely to make their money back, and that's not going to be in antibiotics," Kinch said. "Drug companies may also be saying, 'We are not making much money on antibiotics, so why bother to stock that product.'"
Kinch thinks government needs to play a bigger role in ensuring that antibiotics are available.
"Generally, the market does a good job of filling needs, however, in this case the market really is not working," he said. "The federal government needs to get involved, because this is fundamentally a public health issue."
Copyright © 2014 HealthDay. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
All good. "Blue moon poster" as in "once in a blue moon". Can't wait for the up list. With no revs it's going to come down to the pipeline. Oh what a pipeline we have! Groundwork is laid. Seeds been planted. Leo gunna make it rain. Time to watch it grow. So psyched Barron Von Greybeard found this company and shared it with me! Long may he live! We're all lucky to be here!
Thanks man. Been here awhile. Longtime lurker blue moon poster. CTIX has the best board on ihub hands down. Learned so much from so many of you. Thank you posting people. Keep up the good work!
If we're using price is right rules I'm guessing 1 dollar!
I was on the bid patiently waiting for most of the day but when I saw that monkey I had to slap the ask! It hypnotized me! Dam you rally monkey (shaking fist vigorously in the air).
In one ear out the other
Solar3D - The next solar powerhouse
Just saw Solar3D SLTD price scroll across the bottom of the screen on CNBC! I first found this stock when it was 0.04! Feel like we've officially arrived. What a long strange trip it's been... GLTA
Solar3D - The next solar powerhouse
A man with a plan. The Next Solar Powerhouse!
Solar3D has a successful business model that differentiates itself from its competitors with a system that identifies and implements a profitable consolidation strategy to accelerate acquisitions to build Solar3D into the next solar powerhouse in an untapped industry. On March 4, 2015, Solar3D completed a public offering with help of Cowen and Company, LLC and raised gross proceeds of $12.5 million in connection with a listing on Nasdaq.
Waiting on the Q and Uplist. Looking for revenue increase over last quarter.
That would be good news IMO.
Senate Introduces A Medical Marijuana Bill To End Federal Prohibition:
The bi-partisan bill was introduced at a press conference by Senators Rand Paul (R-Ky.), Cory Booker (D-N.J.), and Kirsten Gillibrand (D-N.Y.). It would also downgrade medical marijuana's Drug Enforcement Agency classification from Schedule 1 to Schedule 2, allowing doctors to recommend its use to some patients like veterans in need, enable more research, and ease banking issues in providing services to the industry.
It says Boeing is printing them and they are out of plastic.
I vote for Sunworks! Great name and all encompassing of business.
CEO's plan
"We want to be first in line to offer an A-Z solution of mobile payments, loyalty card platform and analytics, cashless atm, mobile cashless atm, mobile advertising, billboard advertising, automatic bank account setup, and financial services exclusively dedicated to the MJ dispensary". (Add in merchandising too through Greenstar!)
In time SING can do all this through their "Connect by Text" and "Pay by Text" services. The ISO deal with Redfynn fills in the gaps by providing hardware which allows SING to operate with little overhead costs. "Connect by Text" and "Pay by Text" can be used for ANY type of retail business not just MJ. People forget that SING already does business outside MJ with their "Text2Bid" for auctions and fundraiser. And finally they have their "Donate by text" for nonprofit charities. Each transaction SING gets a small percentage. Those small percentages add up. Imagine in the future how many transactions we'll see in the cannabis business. Takes time to build. Quarterly report released soon. Has to be out before March ends. Still believe we up list. Just my opinions. Waiting patiently. Ignoring the noise. GLTA.
Reminder:
Solar3D believes that 2015 full year revenues will be in the range of $40 million to $45 million. Included in projected revenues for 2015 are sales from the Company's SUNworks division and newly-acquired MD Energy division. MD Energy is anticipated to generate approximately $7 million in revenue for 2014, with substantial growth expected for 2015.
Happy to be back in today. Bright future IMO.
When we were on the OTC you were calling for it to fall back to 0.12. Pretty much there now. Why are you calling for such a dramatic decrease now? What happens if news hits?
Congrats everyone on the uplisting! I'm a former long who sold all his shares a month ago after seeing too many of what I wrongly perceived has fluff PR's. Got tired of waiting for the Cell. Happy for everybody. This a great board with some good people. I'll have to get back in when I can. Again Congratulations! Few penny stocks achieve this. GL
IMO it will. Quarterly release can happen any day this month and uplisting happening soon. Just need more eyes on it and it will run IMO. GL
News out
Easton Pharmaceuticals Inc. Provides Update on the AMFIL GroZone Technology for the Medical Marijuana Industry and Moves Towards Implementation Within Medicated Markets California Operations
TORONTO, ON--(Marketwired - Mar 2, 2015) - Easton Pharmaceuticals Inc. (OTC PINK: EAPH) Provides update on the AMFIL GroZone technology and its related investment in AMFIL Technologies Inc. for the medical marijuana industry; Moves towards implementation in Medicated Markets, California Medical Marijuana Operations. Highlights projected goals towards the venture for the month of March.
Unless that employee already owns a ton of stock and is so confident in the future payouts that they can go and get paid peanuts working for a non profit organization and do something meaningful with their lives. Speculation works both ways.
Because the other stock was obvious to any one who did their DD. If you were fooled there why would I trust your judgement here? This is not a scam. Do your DD. Show us the proof?
I like your post in late September:
"Dude, keep it simple. Greenstar has sales. End of discussion. Quit speculating and lets talk facts".
SING is not a scam. Just because you invested in Newbauer and got taken don't project your failings here. Real company with real revenues. Low float stock with no dilution.
Maybe that guy should stop asking on facebook and go to SING's investor relations page on the updated website and ask there. The facebook page is not the place to ask such questions and its ridiculous that an investor doesn't understand how bad it looks to potential customers. I get it. People are frustrated at their slow pace and lack of updates explaining what's going on. But we don't know what's going on behind the scenes. So it comes down to trust. If you don't trust the people working at SING then sell your shares and move on. I'll never understand people who sell and then hang around to bash the company. For a pink sheet stock SING has not checked off all my boxes to lose my trust. So I patiently wait and believe that SING will be up listing in the near future. The new and improved website is up and ready for the world to see. The 30 day requirement has been met. If SING has not up listed by the end of March then I will reassess my position.
The transparency will increase when we up list. They have to tell us more on the QB. And the webpage is not the same! Did you just go to the front page and not dig in? It's really well done IMO. Much clearer to the potential customers on what they offer. It's designed with SEO principles in mind. (Search Engine Optimization) Additionally they've got an expanded investor section. Ask them a question.
We need some more of those! Too many negative perceptions around here. Not you though. love your positive attitude.
If you think I'm Greg than you're the one going crazy:) like I already explained to you I always assumed that SING was starting the process of having their financials audited and filling out the paper work when he tweeted that. I'm sorry you interpreted it differently. But you maybe right about next week not being the PR for up list. Might be the week after. I'm just assuming they've got everything ready to go now and may have already submitted the paperwork and paid the fee and was just waiting for the final box to check with the 30 day above a penny requirement. We'll see. Sorry you're so frustrated with the company. Hope you make some money off your remaining shares. GL
Looks like someone is purposely supporting it too! 100 shares for 0.014! I like this person much better! Cost them a buck forty! Lol! Thanks Big spender.
Someone is trying to purposely drive this down. A 1667 share sale at the bid for 0.0114! Really! 19 dollars! Last ditch effort to try and sabotage SING's 30 days above a penny maybe? Sure looks like it IMO.
I'm expecting up listing news next week. Since today is 30 days above a penny it Could happen as soon as tomorrow but more likely next week IMO.
It's crazy how under the radar we are! You look at a company like BLOZF which has no revenues and has yet to show a prototype for their cannabis breathalyzer and they're trading in the 0.40 range with the high in the 0.60's! Granted they have less shares but SING has products and services and actual revenue and it sits at this low price. What a bargain! Just a matter of time IMO before people realize the massive potential SING has. Looking forward to news!
Agreed Crisco. Nice volume today. People getting some nice bargains before the news hits. IMO
Quote from last PR
CEO Greg Lambrecht states,"I am very happy to have completed the GreenStar acquisition, and look forward to expanding into territory notably familiar to me while we continue harvesting opportunities and relationships in the legalized cannabis sector."
Yes they are still in the Cannabis business. Was that really a question or are you buying more today before the News? Lol ;) cut it out!) just slap the ask and be done with it. GL!
Very true! No reason why we can't crush this!
You're very welcome. I'm hoping for substantial news too. Got a good feeling but there's no guarantees in the world of pennies. I got into SING last year knowing it's a patience play because of the nature of the industry their involved in. But now 4 states have legalized it and 23 states and Washington DC have medicinal cannabis. The industry is starting to really get going. SING is located in the perfect location to take advantage of both recreational and medicinal. Located in Seattle Washington where it's legal. North of them Alaska just went legal. South of them Oregon voted to legalize. Colorado is a stoned throw away. California has a huge Medicinal market and it's just a matter of time before they legalize. Nevada has medicinal. Arizona isn't far and they have medicinal. Throw in there Montana and New Mexico also medicinal and SING doesn't have to go far to find a lot of their customers. Incredible opportunity IMO.